Trials / Completed
CompletedNCT06180096
Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets
Single Dose Oral Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and 'Adempas' (Riociguat) 2.5 mg Filmtabletten (Film Coated Tablets) in Healthy Adult Male Subjects Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Humanis Saglık Anonim Sirketi · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Single dose oral bioequivalence study of Riociguat 2.5 mg film coated tablets and 'Adempas' (Riociguat) 2.5 mg Filmtabletten (film coated tablets) in healthy adult male subjects under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Riociguat film coated tablets | 1 tablet of 2.5 mg Riociguat |
| DRUG | Adempas Filmtabletten | 1 tablet of 2.5 mg Riociguat |
Timeline
- Start date
- 2023-03-07
- Primary completion
- 2023-03-17
- Completion
- 2023-04-06
- First posted
- 2023-12-22
- Last updated
- 2023-12-28
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT06180096. Inclusion in this directory is not an endorsement.